Xenon Pharmaceuticals Inc. Share Price
XENEXenon Pharmaceuticals Inc. Stock Performance
Open $54.69 | Prev. Close $55.06 | Circuit Range N/A |
Day Range $54.69 - $55.59 | Year Range $28.19 - $63.50 | Volume 12,877 |
Average Traded $55.30 |
Xenon Pharmaceuticals Inc. Share Price Chart
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Xenon Pharmaceuticals Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
11-May-26 | $56.33 | $55.81 | -0.99% |
08-May-26 | $55.98 | $56.37 | +0.75% |
07-May-26 | $57.22 | $55.95 | -4.39% |
06-May-26 | $57.97 | $58.52 | +1.36% |
05-May-26 | $58.18 | $57.73 | +0.64% |
04-May-26 | $56.49 | $57.37 | +2.25% |
01-May-26 | $56.23 | $56.10 | +0.06% |